Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1251837.RAFtpb7n7S28Ewj9-wiLzp1EGB8Ucz2Gn6s-XyUB-8y2g#assertion> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion wasGeneratedBy ECO_0000203 provenance.
- assertion wasDerivedFrom BEFREE provenance.
- assertion SIO_000772 24627085 provenance.
- assertion evidence source_evidence_literature provenance.
- assertion description "[Here, we showed that prostate cancer cells with mutant p53 were resistant to the poly(ADP-ribose) polymerase inhibitor, veliparib (2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, dihydrochloride; Abbott Laboratories, Abbott Park, IL), and the DNA-damaging topoisomerase I inhibitor camptothecin-11 (CPT-11) or SN38 (7-ethyl-10-hydroxycamptothecin) under hypoxia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.